INTRODUCTION
============

The Thoroughbred is the most famous breed for horse racing because of its speed and agility. The Thoroughbred industry as a large agribusiness creates annual revenue of around \$34 billion in the United States alone, and provides about 470,000 jobs related to the network of farms, training centers and race tracks. Genes related to their athletic phenotypes have not been identified, although physical and physiological adaptations related to the potentials of their superior athleticism are well characterized ([@b9-ajas-28-6-870]).

In a previous study, the whole transcriptome for blood and muscle tissues of six Thoroughbred horses before and after 30 min of exercises were analyzed using RNA-sequencing. From the analysis, 32,361 unigene clusters were identified, of which 20,428 have been newly reported as belonging to the equine gene model. Differentially expressed genes were also found in blood (142) and muscle (1,163). In addition, alternative splicing forms of cytoplasmic dynein 1 (*DYNC1*), AXL receptor tyrosine kinase (*AXL*), pleckstrin homology domain containing, family G (with RhoGef Domain) member 1 (*PLEKHG1*), and the cordon-bleu WH2 repeat protein-like 1 (*COBLL1*) showed reversed expression patterns before and after exercise in skeletal muscle ([@b17-ajas-28-6-870]).

The *COBLL1* gene was originally cloned from the human brain cDNA library and is highly expressed in most human tissues including lung, liver, kidney, pancreas, ovary, spinal cord and brain ([@b16-ajas-28-6-870]). *COBLL1* was identified as another class of *Cobl* ([@b3-ajas-28-6-870]). *COBLL1* has been reported as a negative regulator of apoptosis in tumor cells ([@b8-ajas-28-6-870]) and has been associated with metabolic diseases related to insulin resistance ([@b14-ajas-28-6-870]). Despite various studies on *COBLL1*, the specific roles of both genes are still unclear, especially in horses. In this study, we focused on the analysis of the *COBLL1* gene which was one of the alternatively spliced genes during exercise. We confirmed alternative splicing forms of *COBLL1* in various horse tissues and examined the expression pattern of each alternative splicing form in response to exercise.

MATERIALS AND METHODS
=====================

Tissue sampling in horse
------------------------

Three male Thoroughbred horses aged 5, 9, and 10 years, which were maintained at Ham-an Racing Horse Resort and Training Center, were used to obtain the blood and skeletal muscle samples before and after exercise. Exercise was performed by trotting at the speed of 13 km/h for 30 min. The National Institute of Subtropical Agriculture, Rural Development Administration, provided three Jeju horses which were used for collecting the tissue samples such as skeletal muscle, kidney, thyroid, lung, appendix, colon, spinal cord and heart. All tissue samples were kept in liquid nitrogen tank until extraction of RNA was done. All procedures were conducted by following the protocol that had been reviewed and approved by the Institutional Animal Care and Use Committee at Pusan National University (protocol numbers: PNU-2013-0417, PNU-2013-0411).

RNA extraction and cDNA synthesis
---------------------------------

Trizol reagent (Invitrogen, Carlsbad, CA, USA) was used to extract total RNA from tissue samples (skeletal muscle, kidney, thyroid, lung, colon, spinal cord, and heart) and leukocytes after exercise in horse, according to the Invitrogen manual. In order to prevent contamination of genomic DNA, RNase-free DNase kit (Qiagen, Venlo, Netherlands) was used according to the manufacturer's operating manual. Total RNA quantification was performed by using a NanoDrop ND-1000 Spectrophotometer. The cDNAs were synthesized in a reaction with oligo-dT primers, moloney-murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA), RNase inhibitor (Promega, USA) and RNase-free ddH~2~O, which were incubated at 37°C for 4 h.

Reverse transcription polymerase chain reaction amplification and sequencing
----------------------------------------------------------------------------

The horse *COBLL1* transcripts were analyzed by reverse transcription polymerase chain reaction (RT-PCR) amplification. The original horse *COBLL1* transcripts were amplified by the primer pairs S (5′-ATTCCCTGGAGTCAGTCCATGCAG-3′) and AS (5′-GGGAAGTGCCTAAAGATGAGGCTG-3′). These primers were designed using the PRIMER3 program (<http://frodo.wi.mit.edu/primer3/>) and sequence information was obtained from the UCSC genome browser (Accession number: NM-001081812.1). The expected sizes of PCR products were 276 bp and 156 bp for *COBLL1a* and *COBLL1b*, respectively. The RT-PCR conditions were as follows: an initial step of 94°C for 4 min, 35 cycles of 94°C for 40 s, 56°C for 1 min, and 72°C for 2 min were performed. The RT-PCR products were analyzed after electrophoresis on a 1.5% agarose gel. *COBLL1a* and *COBLL1b* were cloned into pGEM-T Easy-cloning vector (Promega, USA) and their nucleotide sequences were determined by Sanger sequencing. The sequenced nucleotides were aligned by Blast (National Center for Biotechnology Information; NCBI, Bethesda, MD, USA).

Real-time quantitative polymerase chain reaction analysis
---------------------------------------------------------

To analyze the expression level of *COBLL1* alternative splicing isoforms in muscle before and after exercise, real-time quantitative polymerase chain reaction **(**RT-qPCR) was conducted by using the BioRad CFX-96 machine (BioRad, Hercules, CA, USA). Primer sequences were designed to detect each type of alternative splicing forms. Two primer pairs, Cobll1a-S (5′-ATCAGTAGACCCGCACGGAA-3′) and Cobll1a-AS (5′-ACACTGACGGAGGAAACCTC-3′) for *COBLL1a*, and Cobll1b-S (5′-AGGGTCTGTCCAGCCCAGCT-3′) and Cobll1b-AS (5′-CCATAACGTGTGGTCCCTGTCC-3′) for *COBLL1b*, were used to specifically detect each isoform. Each reaction was executed in a total 25 μL of mixture containing 14 μL of SYBR green master mix, 2 μL of forward primer (5 pmol), 2 μL of reverse primer (5 pmol), 5 μL of distilled water, and 2 μL (50 ng/μL) of cDNA. The PCR conditions were at 94°C for 5 min of pre-denaturation step, 39 cycles of 94°C for 20 s, 56°C for 20 s and 72°C for 30 s, and followed by 72°C for 10 min as a final step. All samples were measured in triplicate to ensure reproducibility, and C~t~ value was used to calculate the fold change by using the 2^−ΔΔCt^ method ([@b11-ajas-28-6-870]). The glyceraldehyde 3-phosphate dehydrogenase gene was used for reference.

Phylogenetic analysis of equine *COBLL1*
----------------------------------------

The amino acid sequences of *COBLL1* of various species were retrieved from the Gene database of NCBI (wild horse, XP_008531702.1; human, NP_055715.3; chimpanzee, XP_003309326.1; mouse, NP_795999.2; rat, XP_006234363.1; cow, XP_002685420.3; dog, XP_005640312.1; chicken, XP_004942872.1; frog, XP_002939319.2). The amino acid sequences were aligned and used for generating phylogenetic tree by using the MUSCLE and Neighbor-Joining methods, respectively, in MEGA6 program ([@b20-ajas-28-6-870]). The web-based protein prediction program, PredictProtein ([www.predictprotein.org](www.predictprotein.org)), was used to predict the secondary and tertiary structure ([@b18-ajas-28-6-870])*.*

RESULTS AND DISCUSSION
======================

Comparison of COBLL1 amino acid sequences among various species and structural analysis of equine *COBLL1* gene according to alternative splicing
-------------------------------------------------------------------------------------------------------------------------------------------------

The horse *COBLL1* gene has 14 exons and 13 introns spanning about 60.5 kb on the chromosome 18 and six transcriptional variants had been predicted in NCBI Gene database. When the amino acid sequences of *COBLL1* were compared among various species, *COBLL1* showed higher identity at the N-terminal sequences containing a Cordon-bleu ubiquitin-like domain than at the C-terminal ([Figure 1A](#f1-ajas-28-6-870){ref-type="fig"}, solid box). Interestingly, one of the alternative splicing forms of *COBLL1* gene had been observed within the Cordon-bleu ubiquitin-like domain of various species including horse, wild horse, human, dog, chimpanzee, and chicken. However, this variant did not seem to affect the function of the domain as it was predicted as the Cordon-bleu ubiquitin-like domain. Another alternative splicing was observed between exon 8 and 10 (with skipping of exon 9) in many species including horse, wild horse, human, mouse, rat, dog, and chicken ([Figure 1A](#f1-ajas-28-6-870){ref-type="fig"}, dashed box). The similarity of amino acid sequences around these sequences was relatively lower than the other N-terminal region shown in [Figure 1A](#f1-ajas-28-6-870){ref-type="fig"}. Horse *COBLL1* was evolutionarily close to cow *COBLL1* while largely divergent from frog ([Figure 1B](#f1-ajas-28-6-870){ref-type="fig"}). *COBLL1* has been known to regulate apoptosis or to be associated with metabolic diseases related to insulin resistance. It has been reported that alternative splicing forms of a gene may be differentially expressed under conditions of wound response, tumorogenesis, embryonic development and response to external stimuli ([@b22-ajas-28-6-870]; [@b19-ajas-28-6-870]; [@b10-ajas-28-6-870]; [@b6-ajas-28-6-870]; [@b12-ajas-28-6-870]). Therefore, we assumed that *COBLL1* was evolutionally conserved through vertebrates, and the expression patterns of the transcript variants were different according to conditions during stimulation.

Validation and expression pattern of splicing variants of equine *COBLL1*
-------------------------------------------------------------------------

In a previous study, two alternative splicing forms of *COBLL1* transcripts were identified in horses ([@b17-ajas-28-6-870]). And they are found in both NCBI (XM_005601553.1 and XM_005601555.1) and Ensembl (ENSECAT00000027104 and ENSECAT00000027105) data base and designated to *COBLL1a* and *COBLL1b*, respectively ([Figure 2A](#f2-ajas-28-6-870){ref-type="fig"}). Specific primers were designed for binding to exon 7 and 8 forward primers and exon 10 reverse primer to confirm the expression of *COBLL1a* and *COBLL1b* in horse. When PCR for horse *COBLL1* transcripts in blood was performed, two transcriptional variants with different sizes (277 bp and 157 bp) were detected ([Figure 2B](#f2-ajas-28-6-870){ref-type="fig"}). Each amplicon for *COBLL1a* and *COBLL1b* transcript was detected with 120 bp difference in size by gel electrophoresis. By sequencing analysis with the amplicons, the deletion of exon 9 was observed in *COBLL1b* as expected ([Figure 2C](#f2-ajas-28-6-870){ref-type="fig"}).

Expression patterns of *COBLL1a* and *COBLL1b* in various tissues and response to exercise
------------------------------------------------------------------------------------------

To investigate the expression patterns of *COBLL1* variants in horse tissues, RT-PCR was conducted with cDNAs from the various tissues including kidney, spinal cord, heart, thyroid, skeletal muscle, colon and lung ([Figure 3A](#f3-ajas-28-6-870){ref-type="fig"}). The *COBLL1a* showed strong expression in the kidney, spinal cord and lung, moderate expression in the heart and skeletal muscle, and low expression in the thyroid and colon. Unlike *COBLL1a* expression, *COBLL1b* was expressed evenly in all tissues. The expression patterns analysis of *COBLL1a* and *COBLL1b* in muscle tissues before and after exercise revealed that the expression of both *COBLL1a* and *COBLL1b* decreased after exercise, but only *COBLL1b* showed significant decrease ([Figure 3B](#f3-ajas-28-6-870){ref-type="fig"}). Thus, it is speculated that *COBLL1a* and *COBLL1b* responded similarly to the effects of exercise in skeletal muscle.

According to a recent genome-wide association study, the human *COBLL1* gene was found to be located at the genomic region associated with a metabolic traits such as fasting insulin level, type 2 diabetes, and triacylglycerol metabolism ([@b15-ajas-28-6-870]; [@b1-ajas-28-6-870]; [@b4-ajas-28-6-870]). In addition, the C allele of *COBLL1* is functionally linked to lower serum insulin levels and insulin resistance in humans ([@b14-ajas-28-6-870]). These two reports suggest that *COBLL1* may play an important role in metabolic pathways, especially in the regulation of glucose uptake by insulin. Generally, exercise increases the uptake of glucose mediated by up-regulation of GLUT4 protein content and leads to enhanced insulin resistance in muscle ([@b7-ajas-28-6-870]; [@b2-ajas-28-6-870]). Given the importance of glucose metabolism in exercise, it is of interest that the regulation of *COBLL1* expression maybe important for regulating glucose level or switching of energy source, possibly through an insulin signaling pathway, in muscle after exercise. Taken together, this information may be helpful to investigate the role of equine *COBLL1* on the metabolic changes related to the athletic performance of racehorses and to develop *COBLL1* as a useful biomarker for athletic performance.

Protein prediction of *COBLL1a* and *COBLL1b*
---------------------------------------------

In analyzing the amino acid sequences of *COBLL1* splicing forms, COBLL1b has a deletion of 40 amino acids due to the exclusion of exon 9 by alternative splicing compared to COBLL1a ([Figure 4A](#f4-ajas-28-6-870){ref-type="fig"}). These sequences were predicted to include three putative phosphorylation sites by casein kinase 1, p38 mitogen-activated protein kinase, and protein kinase C ([Figure 4B](#f4-ajas-28-6-870){ref-type="fig"}). In many cases, protein phosphorylation is closely related to the control of protein stabilization, serving as a marker that triggers subsequent ubiquitination, in particular where ubiquitination leads to degradation ([@b21-ajas-28-6-870]; [@b5-ajas-28-6-870]; [@b13-ajas-28-6-870]). Therefore, *COBLL1a* could be elaborately controlled in each tissue, whereas *COBLL1b* could be stable in various tissues due to lack of these phosphorylation sites by alternative splicing ([Figure 3A](#f3-ajas-28-6-870){ref-type="fig"}).
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![Analysis of amino acid sequences and phylogenetic tree of COBLL1 among various species. (A) Alignment of N-terminal amino acid sequences of *COBLL1* from various species. The sequences were aligned by the MUSCLE method in MEGA6 program. The N-terminal sequences showed higher similarity among the species compared to C-terminal sequences. The Cordon-bleu ubiquitin-like domain is marked by solid box and the sequences deleted by alternative splicing are marked by dashed box. (B) Phylogenetic tree of *COBLL1*. The phylogenetic tree was made with the full amino acid sequence of each species by Neighbor-Joining method after aligned by the MUSCLE method in MEGA6 program. Horse *COBLL1* was similar to cow and dog while divergent from frog and chicken. COBLL1, cordon-bleu WH2 repeat protein-like 1.](ajas-28-6-870f1){#f1-ajas-28-6-870}

![Alternative splicing of equine *COBLL1* gene. (A) Genomic structures of *COBLL1* alternative splicing variants. Horse *COBLL1* gene, which has 14 exons, has two major alternative splicing forms, *COBLL1a* and *COBLL1b*. The *COBLL1b* has a deletion of exon 9 by alternative splicing. (B) Confirmation of *COBLL1* alternative splicing variants. The alternative splicing variants of *COBLL1* gene, *COBLL1a* and *COBLL1b*, were amplified by RT-PCR with a primer set flanking the alternative splicing region. (C) Sequencing of alternative splicing region. The RT-PCR products were sequenced and confirmed that exon 9 was deleted in *COBLL1b* by alternative splicing. COBLL1, cordon-bleu WH2 repeat protein-like 1; RT-PCR, reverse transcription polymerase chain reaction.](ajas-28-6-870f2){#f2-ajas-28-6-870}

![Expression patterns of equine *COBLL1* alternative splicing variants. (A) Expression of *COBLL1a* and *COBLL1b* genes were analyzed in various tissues. The numbers shown in each lane represent tissues in order of kidney, spinal cord, heart, thyroid, skeletal muscle, colon, and lung. (B) Expression of *COBLL1* alternative splicing variants was analyzed by RT-qPCR in skeletal muscle before and after exercise. COBLL1, cordon-bleu WH2 repeat protein-like 1; RT-qPCR, real-time quantitative polymerase chain reaction.](ajas-28-6-870f3){#f3-ajas-28-6-870}

![The comparison of amino acid sequences between *COBLL1a* and *COBLL1b* proteins. The amino acid sequences of *COBLL1a* and *COBLL1b* proteins were aligned (A), and the putative phosphorylation positions within the alternative splicing region were predicted (B). COBLL1, cordon-bleu WH2 repeat protein-like 1.](ajas-28-6-870f4){#f4-ajas-28-6-870}
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